CureMatch Articles & News
When it comes to cancer treatment in Mexico, just like in the United States, many cancer patients and their doctors still rely on traditional “one-size-fits-all” methods of care. CureMatch is looking to extend Precision Medicine technology to doctors and facilities responsible for any cancer treatment in Mexico.
CureMatch’s CEO Stephane Richard (@StephR1chard) is attending the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. With over 32,000 oncology professionals in attendance, we recommend you connect with Steph directly on social media to set up a meeting.
SOTERIA Precision Medicine Advisory, Inc. and CureMatch, Inc. have entered into an agreement that will facilitate the delivery of Personalized Combination Therapy® options to the global cancer care community. As a premier concierge precision medicine advisory company, Soteria provides client guidance related to individualized tumor profiling services. In turn, CureMatch evaluates a patient’s sequencing data and prior drug history to rank the top mono-therapies, two-drug combinations, and three-drug combinations along with any specifically selected treatment options for the oncologists’ consideration.
A featured article in The Scientist magazine highlights CureMatch co-founder Dr. Razelle Kurzrock and her clinical use of personalized drug combinations therapies at the Center for Personalized Cancer Therapy at the University of California, San Diego. The advances in personalized cancer treatments appear to lead to better results for cancer patients. Check out the entire […]
Exciting results obtained by our decision-support platform - we presented our research at #AACR2018 and showed other cancer researchers our discovery of how CureMatch is revolutionizing Cancer treatment today. This study highlights the possible benefits of an evidence-based selection of personalized therapy options in terms of patient response, and validates the data mining methods and optimized algorithms used by the CureMatch PreciGENE® therapeutic decision-support system.